Showing results (1121-1130 of 3,262) with videos related to

Sort By:
Pageof 327
Biochemical and Biophysical Research Communications|September 19, 2002
Isolation and characterization of Sphingomonas sp. GTIN11 capable of carbazole metabolism in petroleumJohn J Kilbane, Amrutha Daram, Javaneh Abbasian, et al.
European Journal of Human Genetics : EJHG|April 18, 2003
Apparent intrachromosomal exchange on the human Y chromosome explained by population historyRalf Kittler, Axel Erler, Silke Brauer, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|April 5, 2012
Long-term effects of nucleus accumbens deep brain stimulation in treatment-resistant depression: evidence for sustained efficacyBettina H Bewernick, Sarah Kayser, Volker Sturm, et al.
Zeitschrift Fur Die Gesamte Innere Medizin Und Ihre Grenzgebiete|June 15, 1983
[Therapy results of acute leukemia 1965-1980]M Kubel, W Helbig, A Bierbaum, et al.
European Journal of Pharmacology|December 30, 1996
The antinociceptive activity of kappa- but not delta-opioid receptor agonists is maintained in morphine-tolerant neuropathic ratsG Catheline, V Kayser, J J Idänpään-Heikkilä, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|August 1, 1990
Mechanism of imipenem resistance acquired by three Pseudomonas aeruginosa strains during imipenem therapyU Vurma-Rapp, F H Kayser, K Hadorn, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 5, 2010
Asymmetric phosphorylation through catalytic P(III) phosphoramidite transfer: enantioselective synthesis of D-myo-inositol-6-phosphatePeter A Jordan, Katherine J Kayser-Bricker, Scott J Miller
Current Hematologic Malignancy Reports|May 22, 2015
Minimal residual disease in acute myeloid leukemia--current status and future perspectivesSabine Kayser, Roland B Walter, Wendy Stock, et al.
Pageof 327